Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 2
2005 5
2006 2
2007 1
2008 2
2009 6
2010 3
2011 3
2012 7
2013 4
2014 5
2015 4
2016 2
2017 1
2018 2
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Results by year
Filters applied: . Clear all
Page 1
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer.
Chanier T, Chames P. Chanier T, et al. Among authors: chames p. Antibodies (Basel). 2019 Jan 21;8(1):13. doi: 10.3390/antib8010013. Antibodies (Basel). 2019. PMID: 31544819 Free PMC article. Review.
A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer.
Del Bano J, Florès-Florès R, Josselin E, Goubard A, Ganier L, Castellano R, Chames P, Baty D, Kerfelec B. Del Bano J, et al. Among authors: chames p. Front Immunol. 2019 Jul 10;10:1593. doi: 10.3389/fimmu.2019.01593. eCollection 2019. Front Immunol. 2019. PMID: 31354732 Free PMC article.
Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F, Bode J, Sukhanova A, Bozrova SV, Saccomano M, Mitkovski M, Krueger JE, Wege AK, Stuehmer W, Samokhvalov PS, Baty D, Chames P, Nabiev I, Alves F. Ramos-Gomes F, et al. Among authors: chames p. Sci Rep. 2018 Mar 15;8(1):4595. doi: 10.1038/s41598-018-22973-8. Sci Rep. 2018. PMID: 29545609 Free PMC article.
Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation.
Scholler P, Nevoltris D, de Bundel D, Bossi S, Moreno-Delgado D, Rovira X, Møller TC, El Moustaine D, Mathieu M, Blanc E, McLean H, Dupuis E, Mathis G, Trinquet E, Daniel H, Valjent E, Baty D, Chames P, Rondard P, Pin JP. Scholler P, et al. Among authors: chames p. Nat Commun. 2017 Dec 6;8(1):1967. doi: 10.1038/s41467-017-01489-1. Nat Commun. 2017. PMID: 29213077 Free PMC article.
Phage Display and Selections on Purified Antigens.
Colazet M, Chames P. Colazet M, et al. Among authors: chames p. Methods Mol Biol. 2018;1827:165-178. doi: 10.1007/978-1-4939-8648-4_9. Methods Mol Biol. 2018. PMID: 30196497
Special Issue: Nanobody.
Chames P, Rothbauer U. Chames P, et al. Antibodies (Basel). 2020 Mar 6;9(1):6. doi: 10.3390/antib9010006. Antibodies (Basel). 2020. PMID: 32155903 Free PMC article.
[Bispecific antibodies, novel therapeutic candidates harnessing the immune system].
Chames P, Wurch T. Chames P, et al. Med Sci (Paris). 2019 Dec;35(12):1072-1082. doi: 10.1051/medsci/2019242. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903920 Free article. Review. French.
Nanobody-CD16 Catch Bond Reveals NK Cell Mechanosensitivity.
González C, Chames P, Kerfelec B, Baty D, Robert P, Limozin L. González C, et al. Among authors: chames p. Biophys J. 2019 Apr 23;116(8):1516-1526. doi: 10.1016/j.bpj.2019.03.012. Epub 2019 Mar 23. Biophys J. 2019. PMID: 30979550 Free PMC article.
Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
Del Bano J, Chames P, Baty D, Kerfelec B. Del Bano J, et al. Among authors: chames p. Antibodies (Basel). 2015 Dec 26;5(1):1. doi: 10.3390/antib5010001. Antibodies (Basel). 2015. PMID: 31557983 Free PMC article. Review.
Bispecific antibodies for cancer therapy.
Chames P, Baty D. Chames P, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):276-83. Curr Opin Drug Discov Devel. 2009. PMID: 19333873 Review.
54 results
Jump to page